SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 15.88p
   
  • Change Today:
      0.000p
  • 52 Week High: 26.10
  • 52 Week Low: 13.63
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 714,589
  • Market Cap: £41.08m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
98.66% above the market average98.66% above the market average98.66% above the market average98.66% above the market average98.66% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
67.02% above the market average67.02% above the market average67.02% above the market average67.02% above the market average67.02% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Price Book Ratio
93.76% below the market average93.76% below the market average93.76% below the market average93.76% below the market average93.76% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Price Chg 3m
80.74% below the market average80.74% below the market average80.74% below the market average80.74% below the market average80.74% below the market average
68.18% below the sector average68.18% below the sector average68.18% below the sector average68.18% below the sector average68.18% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
53.25% below the market average53.25% below the market average53.25% below the market average53.25% below the market average53.25% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Momentum 20
39.05% below the market average39.05% below the market average39.05% below the market average39.05% below the market average39.05% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
84.96% below the market average84.96% below the market average84.96% below the market average84.96% below the market average84.96% below the market average
35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
63.36% below the market average63.36% below the market average63.36% below the market average63.36% below the market average63.36% below the market average
47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average47.62% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
79.03% below the market average79.03% below the market average79.03% below the market average79.03% below the market average79.03% below the market average
35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average35.71% below the sector average
Operating Profit Loss
64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
74.49% below the market average74.49% below the market average74.49% below the market average74.49% below the market average74.49% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average
Cash
62.58% below the market average62.58% below the market average62.58% below the market average62.58% below the market average62.58% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.88p
Change Today 0.000p
% Change 0.00 %
52 Week High 26.10
52 Week Low 13.63
Volume 714,589
Shares Issued 258.78m
Market Cap £41.08m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
16:18 500,000 @ 16.25p
11:42 15,000 @ 15.81p
11:28 1,329 @ 16.24p
10:53 6 @ 16.24p
10:50 63,337 @ 15.81p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page